ArticleScientific reports2025
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer.
Lorenzo Castagnoli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it